 Its an unforgettable day for Ginkgo Bioworks NYSE: DNA as the company just disclosed a deal with pharmaceutical giant Merck NYSE: MRK . Together, the two companies hope to innovate pharmaceutical manufacturing processes through the use of enzyme technology. 